Hongmei X. Sun
Jiamusi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 04, 2026
Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.
Journal: Future oncology (London, England)
Published: June 03, 2026
Updated survival outcomes of SYHX2011 versus albumin-bound paclitaxel in advanced breast cancer: A randomized double-blind phase III trial.
Journal: Biomolecules & biomedicine
Published: April 23, 2026
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.
Journal: Lancet (London, England)
Published: April 23, 2026
Trans-ancestry meta-analysis of genome-wide association study identifies eight novel genetic loci in type 1 diabetes: A multi-population study.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: March 10, 2026
CYCLING DOF FACTOR 2 (LdCDF2) functions as a positive regulator integrating GA signaling and biosynthesis to drive bulb germination in Lilium.
Journal: Plant physiology
Published: March 02, 2026
Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Phase III Study.
Journal: Cancer communications (London, England)
Published: December 09, 2025
LmCCS Impacts the Flower Colour of Lily by Manipulating the Carotenoid Metabolic Flux.
Journal: Physiologia plantarum
Published: November 25, 2025
A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis.
Journal: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Published: November 10, 2025
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 05, 2025
Burden trends and risk factors for prostate cancer from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021.
Journal: Expert review of anticancer therapy
Published: September 01, 2025
Plasma Protein Fluctuation Trajectories Over 15 Years Before Rheumatoid Arthritis Onset.
Journal: Immunology
Published: August 11, 2025
Last Updated: 09/26/2026